Electrogram morphology discriminators in implantable cardioverter defibrillators: A comparative evaluation

被引:7
作者
Frontera, Antonio [1 ,2 ]
Strik, Marc [1 ,2 ,3 ]
Eschalier, Romain [4 ]
Biffi, Mauro [5 ]
Pereira, Bruno [4 ]
Welte, Nicolas [1 ]
Chauvel, Remi [1 ]
Mondoly, Pierre [6 ]
Laborderie, Julien [7 ]
Bernis, Jean-Paul [7 ]
Clementy, Nicolas [8 ]
Reuter, Sylvain [9 ]
Garrigue, Stephane [9 ]
Deplagne, Antoine [10 ]
Vernooy, Kevin [3 ,11 ]
Pillois, Xavier [1 ,2 ]
Haissaguerre, Michel [1 ,2 ]
Dubois, Remi [2 ]
Ritter, Philippe [1 ,2 ]
Bordachar, Pierre [1 ,2 ]
Ploux, Sylvain [1 ,2 ]
机构
[1] Bordeaux Univ Hosp CHU, Cardio Thorac Unit, Pessac, France
[2] Fondat Bordeaux Univ, Electrophysiol & Heart Modeling Inst, IHU Liryc, Bordeaux, France
[3] Maastricht Univ, Cardiovasc Res Inst Maastricht, Physiol & Cardiol Dept, Med Ctr, Maastricht, Netherlands
[4] Univ Clermont Auvergne, Inst Pascal, Cardiol Dept, CHU Clermont Ferrand, Clermont Ferrand, France
[5] Azienda Osped Univ Bologna, Bologna, Italy
[6] Univ Hosp Rangueil, Toulouse, France
[7] CH Bayonne, Bayonne, France
[8] CHU Tours, Cardiol Dept, Tours, France
[9] St Augustin Clin, Cardiol Dept, Bordeaux, France
[10] Robert Boulin Hosp, Cardiol Dept, Libourne, France
[11] Radboud Univ Nijmegen, Dept Cardiol, Med Ctr, Nijmegen, Netherlands
关键词
algorithm; arrhythmia; discrimination; implantable cardioverter defibrillator; morphology; SUPRAVENTRICULAR TACHYCARDIA; VENTRICULAR-TACHYCARDIA; RHYTHM DISCRIMINATION; DUAL-CHAMBER; ALGORITHM;
D O I
10.1111/jce.14518
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Morphology algorithms are currently recommended as a standalone discriminator in single-chamber implantable cardioverter defibrillators (ICDs). However, these proprietary algorithms differ in both design and nominal programming. Objective To compare three different algorithms with nominal versus advanced programming in their ability to discriminate between ventricular (VT) and supraventricular tachycardia (SVT). Methods In nine European centers, VT and SVTs were collected from Abbott, Boston Scientific, and Medtronic dual- and triple-chamber ICDs via their respective remote monitoring portals. Percentage morphology matches were recorded for selected episodes which were classified as VT or SVT by means of atrioventricular comparison. The sensitivity and related specificity of each manufacturer discriminator was determined at various values of template match percentage from receiving operating characteristics (ROC) curve analysis. Results A total of 534 episodes were retained for the analysis. In ROC analyses, Abbott Far Field MD (area under the curve [AUC]: 0.91; P < .001) and Boston Scientific RhythmID (AUC: 0.95; P < .001) show higher AUC than Medtronic Wavelet (AUC: 0.81; P < .001) when tested for their ability to discriminate VT from SVT. At nominal % match threshold all devices provided high sensitivity in VT identification, (91%, 100%, and 90%, respectively, for Abbott, Boston Scientific, and Medtronic) but contrasted specificities in SVT discrimination (85%, 41%, and 62%, respectively). Abbott and Medtronic's nominal thresholds were similar to the optimal thresholds. Optimization of the % match threshold improved the Boston Scientific specificity to 79% without compromising the sensitivity. Conclusion Proprietary morphology discriminators show important differences in their ability to discriminate SVT. How much this impact the overall discrimination process remains to be investigated.
引用
收藏
页码:1493 / 1506
页数:14
相关论文
共 50 条
[31]   Is there a role for implantable cardioverter defibrillators in long QT syndrome? [J].
Wilde, AAM .
JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY, 2002, 13 (01) :S110-S113
[32]   Sensing and tachyarrhythmia detection problems in implantable cardioverter defibrillators [J].
Reiter, MJ ;
Mann, DE .
JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY, 1996, 7 (06) :542-558
[33]   EXPERIENCES WITH IMPLANTABLE CARDIOVERTER-DEFIBRILLATORS OF NEWER GENERATION [J].
SEN, S ;
HEISEL, A ;
KALWEIT, G ;
FRIES, R ;
PETZOLD, T ;
JUNG, J ;
OZBEK, C ;
VOLKMER, I ;
GAMS, E .
HERZ KREISLAUF, 1994, 26 (05) :158-163
[34]   Implantable cardioverter defibrillators in the prevention of sudden cardiac death [J].
Bockeria, L. A. ;
Neminushchiy, N. M. ;
Mikhaylichenko, S. I. ;
Novichkov, S. A. ;
Achkasov, E. E. .
TERAPEVTICHESKII ARKHIV, 2017, 89 (12) :103-109
[35]   Adjuvant Antiarrhythmic Therapy in Patients with Implantable Cardioverter Defibrillators [J].
T. Jared Bunch ;
Jeffrey L. Anderson .
American Journal of Cardiovascular Drugs, 2014, 14 :89-100
[36]   Role of antiarrhythmic drugs in patients with implantable cardioverter defibrillators [J].
Van Herendael, Hugo ;
Pinter, Arnold ;
Ahmad, Kamran ;
Korley, Victoria ;
Mangat, Iqwal ;
Dorian, Paul .
EUROPACE, 2010, 12 (05) :618-625
[37]   Implantable cardioverter defibrillators and their role in heart failure progression [J].
Cevik, Cihan ;
Perez-Verdia, Alejandro ;
Nugent, Kenneth .
EUROPACE, 2009, 11 (06) :710-715
[38]   Reduction of inappropriate implantable cardioverter-defibrillator therapies using enhanced supraventricular tachycardia discriminators: the ReduceIT study [J].
Geller, Johann Christoph ;
Woehrle, Armin ;
Busch, Mathias ;
Elsaesser, Albrecht ;
Kleemann, Thomas ;
Birkenhauer, Frank ;
Bramlage, Peter ;
Veltmann, Christian .
JOURNAL OF INTERVENTIONAL CARDIAC ELECTROPHYSIOLOGY, 2021, 61 (02) :339-348
[39]   A new algorithm for rhythm discrimination in cardioverter defibrillators based on the initial voltage changes of the ventricular electrogram [J].
Rojo-Alvarez, JL ;
Arenal, A ;
García-Alberola, A ;
Ortiz, M ;
Valdés, M ;
Artés-Rodríguez, A .
EUROPACE, 2003, 5 (01) :77-82
[40]   Health economic evaluation of implantable cardioverter defibrillators in hypertrophic cardiomyopathy in adults [J].
Magnusson, Peter ;
Wimo, Anders .
INTERNATIONAL JOURNAL OF CARDIOLOGY, 2020, 311 :46-51